Basics Fortress Biotech, Inc. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products. IPO Date: December 1, 2011 Sector: Healthcare Industry: Biotech Market Cap: $56.48M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 3.64% Avg Daily Range (30 D): $0.05 | 2.51% Avg Daily Range (90 D): $0.05 | 2.67% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): .2M Avg Daily Volume (90 D): .22M Trade Size Avg Trade Size (Sh.): 218 Avg Trade Size (Sh.) (30 D): 234 Avg Trade Size (Sh.) (90 D): 221 Institutional Trades Total Inst.Trades: 36 Avg Inst. Trade: $2.41M Avg Inst. Trade (30 D): $1.09M Avg Inst. Trade (90 D): $1.09M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.49M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 11.5K     News May 30, 2025 @ 2:47 PM Fortress Biotech Announces Closing of Sale of Subs... Source: Globe Newswire May 7, 2025 @ 12:00 PM Fortress Biotech to Participate in the H.C. Wainwr... Source: N/A Feb 10, 2025 @ 1:00 PM Mustang Bio Announces Closing of $8 Million Public... Source: N/A Feb 6, 2025 @ 12:00 PM Mustang Bio Announces Pricing of $8 Million Public... Source: Globe Newswire Feb 6, 2025 @ 12:00 PM Mustang Bio Announces Pricing of $8 Million Public... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.48 $-.26 $-2.69 Diluted EPS $-.48 $-.26 $-2.69 Revenue $ 13.14M $ 15.12M $ 57.68M Gross Profit $ 8.35M $ 12.88M $ 36.8M Net Income / Loss $ -24.69M $ -26.32M $ -120.86M Operating Income / Loss $ -22.32M $ -23.84M $ -110.38M Cost of Revenue $ 4.79M $ 2.24M $ 20.88M Net Cash Flow $ 33.74M $ -24.55M $ -24.55M PE Ratio     Splits Oct 10, 2023:   1:15 Dec 06, 2022:   1:10